Description:
NEURAMINIDASE DEFICIENCY
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Lysosomal Storage Diseases |
| Class |
Disorders of Carbohydrate Metabolism |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Race
|
White
|
|
Family Member
|
1
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
9 |
| |
| exo-alpha-sialidase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.2.1.18; 8% activity. |
| |
| Remarks |
6 times the normal level of sialic acid in fibroblasts; approximately 8% of normal sialidase activity |
| Pshezhetsky AV, Potier M, Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate. J Biol Chem271:28359-65 1996 |
| PubMed ID: 8910459 |
| Gene Cards |
NEU |
| NCBI GTR |
256550 NEURAMINIDASE DEFICIENCY |
| OMIM |
256550 NEURAMINIDASE DEFICIENCY |
| Omim Description |
CHERRY RED SPOT AND MYOCLONUS SYNDROME |
| |
GLYCOPROTEIN NEURAMINIDASE, DEFICIENCY OF |
| |
LIPOMUCOPOLYSACCHARIDOSIS, INCLUDED |
| |
ML I, INCLUDED |
| |
MUCOLIPIDOSIS I, INCLUDED |
| |
MYOCLONUS AND CHERRY RED SPOT SYNDROME |
| |
NEU, DEFICIENCY OF |
| |
NEU1, DEFICIENCY OFNEURAMINIDASE, INCLUDED; NEU, INCLUDED |
| |
NEUG, DEFICIENCY OF |
| |
NEURAMINIDASE 1, DEFICIENCY OF |
| |
NEURAMINIDASE DEFICIENCY |
| |
SIALIDASE DEFICIENCY |
| |
SIALIDOSES, TYPES I AND II |
| Passage Frozen |
9 |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|